GeneDx Holdings Corp. (WGSWW)
Market Closed
21 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 00
-0.01
-92.3077%
$
514.45M Market Cap
- P/E Ratio
- Div Yield
800,000 Volume
0 Eps
$ 0.01
Previous Close Investors:
Want to track WGSWW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
WGSWW closed Tuesday lower at $0, a decrease of -92.3077% from Monday's close, completing a monthly decrease of -83.7838% or $0. Over the past 12 months, WGSWW stock lost -98.5%.
WGSWW is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
GeneDx Holdings Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 100 | $0.78 | $0.07 | -$0.71 | -91.03% |
GeneDx Holdings Corp. (WGSWW) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
GeneDx Holdings Corp. is listed on NASDAQ (NGS).
What is its stock symbol?
The ticker symbol is WGSWW.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 514.45M.
Has GeneDx Holdings Corp. ever had a stock split?
No, there has never been a stock split.
GeneDx Holdings Corp. Profile
| Biotechnology Industry | Healthcare Sector | Katherine A. Stueland CEO | NASDAQ (NGS) Exchange | 81663L119 CUSIP |
| US Country | 1,300 Employees | - Last Dividend | - Last Split | 4 Nov 2020 IPO Date |
Overview
GeneDx Holdings Corp. is a pioneering entity in the field of genomics, delivering a wide array of diagnostic and information services through its subsidiaries since its inception in 2017. Headquartered in Stamford, Connecticut, the company strides ahead with a robust commitment to enhancing healthcare through genomics. It stands out in the medical community for integrating advanced digital tools and artificial intelligence within its operations, which significantly boosts its capability to offer comprehensive health insights. The focus on pediatrics, rare diseases for both children and adults, as well as hereditary cancer screening, positions GeneDx Holdings Corp. as a key player in the advancement of personalized and precision medicine.
Products and Services
- Centrellis Health Intelligence Platform - An AI-driven platform that revolutionizes the way health data is used. Centrellis integrates digital tools and artificial intelligence, enabling researchers and scientists to efficiently ingest, process, and synthesize clinical and genomic data. This integration facilitates the delivery of comprehensive health insights, aiding in the advancement of personalized medicine and enhancing patient care outcomes.
- Genetic Diagnostic Tests - GeneDx Holdings Corp. offers an extensive range of genetic diagnostic tests aimed at identifying genetic disorders at an early stage. These tests are pivotal in detecting a variety of conditions, enabling healthcare providers to devise appropriate treatment and management plans tailored to the individual needs of patients.
- Screening Solutions - The company provides state-of-the-art screening solutions that play a crucial role in preemptive health care. These solutions are designed to detect potential health issues before they become serious, thereby enabling timely intervention and reducing the overall healthcare burden.
- Information Services - With a strong emphasis on pediatrics, rare diseases, and hereditary cancer screening, GeneDx Holdings Corp. extends comprehensive information services. These services are rooted in the latest research and innovations in genomics, offering invaluable support to both healthcare providers and patients in navigating complex health conditions and making informed decisions.
Contact Information
Address: North Tower
Phone: 888 729 1206
Website: https://www.genedx.com
